Form 4 Tracker
Viking Therapeutics, Inc.
VKTX

2 insider filings · Latest: Mar 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 20, 2024Sep 20 8:13 PMSINGLETON J MATTHEW
Proposed Sale
10,300$69.50$715.9K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 12, 2026Jan 27 12:57 AMNeil William AubuchonChief Commercial Officer
Grant/Award
180,000$31.76180,000(D)

View →